Skip to content
Screener

uniQure QURE Other Income (Expense)

Other Income (Expense) at other companies

Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
-$15.04M-140%
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
$1.08M+1,096%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$1.61M+126%
Design Therapeutics, Inc. logo
Design Therapeutics, Inc.DSGN
$3.21M+5.7%
Candel Therapeutics, Inc. logo
Candel Therapeutics, Inc.CADL
$7.42M-52.1%
Regenxbio logo
RegenxbioRGNX
-$6.55M+13.7%

Segments

By segment

See full
Single Reportable-$1.73M-109%

Other financials

Income statement

See full
Revenue$5.8M+11.0%
Gross profit$5.5M+19.2%
Operating income-$52.2M-19.0%
Net income-$81.1M-115%
EPS (diluted)-$1.22-76.8%

Balance sheet

See full
Cash & equivalents$413.0M+62.8%
Total debt$62.8M-5.8%
Total equity$324.1M+8,195%
Total assets$985.1M+68.4%

Cash flow

See full
Operating cash flow-$28.6M+28.4%
CapEx$472.0K+81.5%
Free cash flow-$29.0M+27.7%

Valuation

See full
Market cap$3.15B+325%
Enterprise value$2.8B+406%
P/S168.5×+117×

Profitability

See full
Gross margin92.5%+4.6pp
Operating margin-1,071.5%-90.6pp
Net margin-1,350.7%-35.3pp
FCF margin-864.7%-194pp

Returns & leverage

See full
Return on equity-228.2%-11.6pp
Debt / equity0.2×
Current ratio10×0.0×

Where this comes from

Reported directly by uniQure in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The source filing: uniQure’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 7:17 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001104659-26-087815
Line itemThree months ended June 30, 2026Three months ended June 30, 2025Six months ended June 30, 2026Six months ended June 30, 2025
Interest income5,0513,52410,2807,651
Interest expense(14,366)(15,591)(28,397)(30,700)
Foreign currency (losses) / gains, net(1,730)18,638(4,024)25,810
Other non-operating (losses), net(15,970)(12,201)
Loss before income tax expense$(79,218)$(37,294)$(132,265)$(80,435)
Income tax expense(1,841)(425)(2,329)(921)
Net loss$(81,059)$(37,719)$(134,594)$(81,356)
Other comprehensive loss:

Item 1.Financial Statements

FAQ

What is uniQure's other income (expense)?
uniQure (QURE) reported other income (expense) of -$15.97M in Q2 2026.
How has uniQure's other income (expense) changed year-over-year?
uniQure's other income (expense) decreased by 714.9% year-over-year, from $2.6M to -$15.97M.
What is the long-term trend for uniQure's other income (expense)?
Over 2 years (2021 to 2025), uniQure's other income (expense) has grown at a 1067.5% compound annual growth rate (CAGR), from -$160K to $21.81M.
What does other income (expense) mean?
Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.

Ask your AI about uniQure's other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude